Blue Water Life Science Advisors
Larkspur, California, United StatesFounded 2017
Blue Water Life Science Advisors is a California-based investment firm that operates as a hedge fund and venture capital investor focusing on the life sciences, healthcare, and biotechnology sectors, with a particular emphasis on precision medicine and genomics. Founded by Nate Cornell, the firm participates in funding rounds from Series B through growth and also makes public-market investments.
Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Average disclosed round size is $94.4M (across 11 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series E
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Ansa Biotechnologies | Series B | $54.4M | Oct 2025 |
 Visby Medical | Growth | $55M | Jun 2025 |
| VVisby | Series E | $65M | Jun 2025 |
| VVisby | Series E | $100M | Jun 2022 |
| Visby Medical | Series E | $135M | Jun 2022 |
 Vizgen | Series C | $85.2M | Jun 2022 |
 SomaLogic | Series A | $214M | Dec 2020 |
| SomaLogic | Series A | $121M | Jan 2020 |
 Pear Therapeutics | Series D | $80M | — |
| Pear Therapeutics | Series C | $64M | — |
| Visby Medical | Series E | $65M | — |
Top Co-Investors
+ND Capital5 shared
Cedars-Sinai Medical Center5 shared
Catalio Capital Management3 shared
J-Ventures3 shared
Lightrock3 shared
Ping An Global Voyager Fund3 shared
Plug and Play Tech Center2 shared
Pitango VC2 shared
Casdin Capital2 shared
Boston Millennia Partners2 shared
T. Rowe Price2 shared
Logos Capital2 shared
Farallon Capital Management2 shared
Revelation Partners2 shared
Novartis Venture Fund2 shared
Soleus Capital2 shared
Foresite Capital2 shared
Redmile Group2 shared
Last updated: 7 October 2026